Related Experiment Video
Updated: Jan 8, 2026

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
Differentiating Glioma from Brain Metastasis Using Neurite Orientation Dispersion and Density Imaging: A Systematic
Amir Mahmoud Ahmadzadeh1, Nima Broomand Lomer2, Sadegh Ghaderi3,4
1From the Department of Radiology, School of Medicine (A.M.A.), Mashhad University of Medical Sciences, Mashhad, Iran.
Neurite orientation dispersion and density imaging (NODDI) parameters, specifically orientation dispersion index (ODI) and isotropic volume fraction (V-ISO), show promise in distinguishing gliomas from brain metastases (BMs). These imaging biomarkers could aid in noninvasive differential diagnosis of brain tumors.
Area of Science:
- Neuroimaging
- Radiology
- Oncology
Background:
- Differentiating gliomas from brain metastases (BMs) is a significant clinical challenge.
- Noninvasive imaging biomarkers are crucial for accurate brain tumor diagnosis.
- Neurite orientation dispersion and density imaging (NODDI) offers potential for improved discrimination.
Purpose of the Study:
- To systematically review studies measuring NODDI parameters in patients with gliomas and BMs.
- To assess the utility of NODDI parameters in differentiating these intracranial tumors.
- To identify specific NODDI metrics valuable for differential diagnosis.
Main Methods:
- A comprehensive literature search was performed across PubMed, Web of Science, Embase, and Scopus.
- Included studies measured NODDI parameters (V-IC, V-ISO, ODI) in glioma and BM patients.
- Meta-analysis utilized random-effects models, assessing heterogeneity and publication bias.
Main Results:
- Ten studies were included in the meta-analysis.
- Significant differences in orientation dispersion index (ODI) and isotropic volume fraction (V-ISO) were found between gliomas and BMs in contrast-enhancing regions.
- V-ISO also showed significant differences in the peritumoral edema area for glioblastoma subgroups.
Conclusions:
- NODDI parameters, particularly ODI and V-ISO, are effective noninvasive biomarkers for differentiating gliomas from BMs.
- These findings support the use of NODDI in improving the differential diagnosis of brain tumors.
- Further research is warranted due to the limited number of studies included.
More Related Videos
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
12:25Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014